In Morocco, the pregnant women living with hiv antiretroviral therapy coverage for pmtct currently stands at 63%, reflecting an increase of 11% (21.2%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Morocco
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Morocco
PMTCT antiretroviral therapy coverage
More indicators for Morocco
Male unintentional poisoning
0.7
0.0
(2019)
Female wasting in children
2.8%
+1%
(2017)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar231
+intl dollar25
(2021)
Birth registration
96.9%
+2.9%
(2018)
Contraceptive modern method prevalence
59.1%
+0.5%
(2018)
Morocco PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 63% | +11% |
| 2021 | 52% | 0% |
| 2020 | 52% | -3% |
| 2019 | 55% | +10% |
| 2018 | 45% | +4% |
| 2017 | 41% | 0% |
| 2016 | 41% | +10% |
| 2015 | 31% | -6% |
| 2014 | 37% | +5% |
| 2013 | 32% | -2% |
| 2012 | 34% | +13% |
| 2011 | 21% | 0% |
| 2010 | 21% | +5% |
| 2009 | 16% | +5% |
| 2008 | 11% | +3% |
| 2007 | 8% | +3% |
| 2006 | 5% | +2% |
| 2005 | 3% | +3% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |